| 000 | 01432 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250513140733.0 | ||
| 264 | 0 | _c19980413 | |
| 008 | 199804s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.1998.00515.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRowbottom, A W | |
| 245 | 0 | 0 |
_aCytomegalovirus (CMV) infection in AIDS patients is associated with a CD3 receptor-mediated T cell hyporesponsiveness. _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cMar 1998 |
||
| 300 |
_a559-63 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAIDS-Related Opportunistic Infections _xblood |
| 650 | 0 | 4 |
_aAcquired Immunodeficiency Syndrome _xblood |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aCD3 Complex _ximmunology |
| 650 | 0 | 4 |
_aCytomegalovirus Infections _xblood |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterleukin-2 _xpharmacology |
| 650 | 0 | 4 |
_aLeukocytes, Mononuclear _xdrug effects |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 |
_aNF-kappa B _xbiosynthesis |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 700 | 1 | _aLepper, M W | |
| 700 | 1 | _aSharpstone, D | |
| 700 | 1 | _aGazzard, B | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 111 _gno. 3 _gp. 559-63 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.1998.00515.x _zAvailable from publisher's website |
| 999 |
_c9496522 _d9496522 |
||